Alcon Secures FDA Approval for TRYPTYR (Acoltremon Ophthalmic Solution) 0.003% for Dry Eye Disease
TRYPTYR, the first TRPM8-targeting eye drop, improves tear production from Day 1 in dry eye patients. Alcon (Geneva, Switzerland) has…
FDA Clears Immunoglobulin Eye Drops for Phase II Dry Eye Trial
Biologic therapy enters clinical study to assess broad anti-inflammatory potential The U.S. FDA has granted IND clearance for a new…
latest posts
